Contents

Search

cilgavimab

Indications: - used in combination with tixagevimab for prevention of Covid-19 * emergency use authorization Dosage: - cilgavimab 150 mg/1.5 mL (100 mg/mL) in a single-dose vial Mechanism of action: - monoclonal antibody specifically directed against the spike protein of SARS-CoV2

Interactions

drug adverse effects of pharmaceutical monoclonal antibodies

General

monoclonal antibody to spike glycoprotein of SARS-CoV2 (COVID-19)

References

  1. MedlinePlus: Tixagevimab and Cilgavimab https://medlineplus.gov/druginfo/meds/a621058.html
  2. HIGHLIGHTS OF EMERGENCY USE AUTHORIZATION (EUA) Evusheld (tixagevimab) injection; (cilgavimab) injection, co-packaged for intramuscular use https://www.fda.gov/media/154701/download